Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Protein–protein interactions

Making drug design second nature

Nature Chemistry volume 1, pages 596–597 (2009)Cite this article

Identifying inhibitors of protein–protein interactions is an ongoing challenge in the field of drug design, but the use of peptide fragments based on a known binding interface is showing promise.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Drug-binding sites and tubulin–tubulin contact regions.

References

  1. Fletcher, S. & Hamilton, A. D. Curr. Top. Med. Chem. 7, 922–927 (2007).

    Article  CAS  Google Scholar 

  2. Robinson, J. A., Demarco, S., Gombert, F., Moehle, K. & Obrecht, D. Drug Discov. Today. 13, 944–951 (2008).

    Article  Google Scholar 

  3. Pieraccini, S. et al. Nature Chem. 1, 642–648 10.1038/nchem.401(2009).

    Article  CAS  Google Scholar 

  4. Banerjee, S., Wang, Z., Mohammad, M., Sarkar, F. H. & Mohammad, R. M. J. Nat. Prod. 71, 492–496 (2008).

    Article  CAS  Google Scholar 

  5. Rubinstein, M. & Niv, M. Y. Biopolymers 91, 505–513 (2009).

    Article  CAS  Google Scholar 

  6. Ofran, Y. & Rost, B. PLoS Comput. Biol. 3, 1169–1176 (2007).

    Article  CAS  Google Scholar 

  7. Zhong, S., Macias, A. T. & MacKerell, A. D. Jr Curr. Top. Med. Chem. 7 63–82 (2007).

    Article  CAS  Google Scholar 

  8. González-Ruiz, D. & Gohlke, H. Curr. Med. Chem. 13, 2607–25 (2006).

    Article  Google Scholar 

  9. Che, Y., Brooks, B. R. & Marshall, G. R. J. Comput. Aided Mol. Des. 20, 109–130 (2006).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dan Sackett is in the Laboratory of Integrative and Medical Biophysics, Program in Physical Biology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, 9 Memorial Drive, Bethesda Maryland 20892-0924, USA. sackettd@mail.nih.gov,

    Dan L. Sackett

  2. David Sept is in the Department of Biomedical Engineering and the Center for Computational Medicine and Bioinformatics at the University of Michigan, 1101 Beal Ave, Ann Arbor, Michigan 4810, USA. dsept@umich.edu,

    David Sept

Authors
  1. Dan L. Sackett
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David Sept
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sackett, D., Sept, D. Making drug design second nature. Nature Chem 1, 596–597 (2009). https://doi.org/10.1038/nchem.427

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nchem.427

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing